GSK to buy Rapt in $2.2B deal for food allergy drug
GSK to buy Rapt in $2.2B deal for food allergy drug
GSK to buy Rapt in $2.2B deal for food allergy drug
A rolling strip of the companies, platforms, CROs and device makers that show up across the coverage.
Open about page